TLR9 and autoimmune disease: TLR-7/8 and TLR-9 agonists are used in mRNA/DNA SARS-CoV-2 vaccinations as “adjuvants,” which may encourage the subset of ABC to produce autoantibodies and post-vaccination autoimmune disorders [203,204].